 | • レポートコード：MRC2Q12-18955 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、補完薬の世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に補完薬のグローバル市場のxxx％を占める「ペプチド」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「血液疾患」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 補完薬の中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの補完薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 補完薬のグローバル主要プレイヤーには、Novartis AG、Alexion Pharmaceuticals、ChemoCentryx、Roche、Apellis、Regeneron、Amgen、Alnylam、UCB、InflaRx、ChemoCentryx、Innate Pharma、Ionis Pharmaceuticals、Avant Immunotherapeutics、Pfizer、Sanofi、Omeros、GenMab、Akari Therapeutics、AbbVieなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 補完薬市場は、種類と用途によって区分されます。世界の補完薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 ペプチド、抗体、その他 【用途別セグメント】 血液疾患、腎臓病、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 補完薬製品概要 - 種類別市場（ペプチド、抗体、その他） - 用途別市場（血液疾患、腎臓病、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の補完薬販売量予測2017-2028 - 世界の補完薬売上予測2017-2028 - 補完薬の地域別販売量 - 補完薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別補完薬販売量 - 主要メーカー別補完薬売上 - 主要メーカー別補完薬価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（ペプチド、抗体、その他） - 補完薬の種類別販売量 - 補完薬の種類別売上 - 補完薬の種類別価格 ・用途別市場規模（血液疾患、腎臓病、その他） - 補完薬の用途別販売量 - 補完薬の用途別売上 - 補完薬の用途別価格 ・北米市場 - 北米の補完薬市場規模（種類別、用途別） - 主要国別の補完薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの補完薬市場規模（種類別、用途別） - 主要国別の補完薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の補完薬市場規模（種類別、用途別） - 主要国別の補完薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の補完薬市場規模（種類別、用途別） - 主要国別の補完薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの補完薬市場規模（種類別、用途別） - 主要国別の補完薬市場規模（トルコ、サウジアラビア） ・企業情報 Novartis AG、Alexion Pharmaceuticals、ChemoCentryx、Roche、Apellis、Regeneron、Amgen、Alnylam、UCB、InflaRx、ChemoCentryx、Innate Pharma、Ionis Pharmaceuticals、Avant Immunotherapeutics、Pfizer、Sanofi、Omeros、GenMab、Akari Therapeutics、AbbVie ・産業チェーン及び販売チャネル分析 - 補完薬の産業チェーン分析 - 補完薬の原材料 - 補完薬の生産プロセス - 補完薬の販売及びマーケティング - 補完薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 補完薬の産業動向 - 補完薬のマーケットドライバー - 補完薬の課題 - 補完薬の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Complement Drug estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Complement Drug is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Complement Drug is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Complement Drug is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Complement Drug include Novartis AG, Alexion Pharmaceuticals, ChemoCentryx, Roche, Apellis, Regeneron, Amgen, Alnylam and UCB, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Complement Drug companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Complement Drug market. Further, it explains the major drivers and regional dynamics of the global Complement Drug market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Novartis AG
Alexion Pharmaceuticals
ChemoCentryx
Roche
Apellis
Regeneron
Amgen
Alnylam
UCB
InflaRx
ChemoCentryx
Innate Pharma
Ionis Pharmaceuticals
Avant Immunotherapeutics
Pfizer
Sanofi
Omeros
GenMab
Akari Therapeutics
AbbVie
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Complement Drug Segment by Type
Peptides
Antibodies
Others
Complement Drug Segment by Application
Blood Disease
Kidney Disease
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Complement Drug market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Complement Drug market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Complement Drug, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Complement Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Complement Drug revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Complement Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Complement Drug revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Novartis AG, Alexion Pharmaceuticals, ChemoCentryx, Roche, Apellis, Regeneron, Amgen, Alnylam and UCB, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Complement Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Complement Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Complement Drug revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Complement Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Peptides
1.2.3 Antibodies
1.2.4 Others
1.3 Market by Application
1.3.1 Global Complement Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Blood Disease
1.3.3 Kidney Disease
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Complement Drug Market Perspective (2017-2028)
2.2 Complement Drug Growth Trends by Region
2.2.1 Complement Drug Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Complement Drug Historic Market Size by Region (2017-2022)
2.2.3 Complement Drug Forecasted Market Size by Region (2023-2028)
2.3 Complement Drug Market Dynamics
2.3.1 Complement Drug Industry Trends
2.3.2 Complement Drug Market Drivers
2.3.3 Complement Drug Market Challenges
2.3.4 Complement Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Complement Drug Players by Revenue
3.1.1 Global Top Complement Drug Players by Revenue (2017-2022)
3.1.2 Global Complement Drug Revenue Market Share by Players (2017-2022)
3.2 Global Complement Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Complement Drug Revenue
3.4 Global Complement Drug Market Concentration Ratio
3.4.1 Global Complement Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Complement Drug Revenue in 2021
3.5 Complement Drug Key Players Head office and Area Served
3.6 Key Players Complement Drug Product Solution and Service
3.7 Date of Enter into Complement Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Complement Drug Breakdown Data by Type
4.1 Global Complement Drug Historic Market Size by Type (2017-2022)
4.2 Global Complement Drug Forecasted Market Size by Type (2023-2028)
5 Complement Drug Breakdown Data by Application
5.1 Global Complement Drug Historic Market Size by Application (2017-2022)
5.2 Global Complement Drug Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Complement Drug Market Size (2017-2028)
6.2 North America Complement Drug Market Size by Type
6.2.1 North America Complement Drug Market Size by Type (2017-2022)
6.2.2 North America Complement Drug Market Size by Type (2023-2028)
6.2.3 North America Complement Drug Market Share by Type (2017-2028)
6.3 North America Complement Drug Market Size by Application
6.3.1 North America Complement Drug Market Size by Application (2017-2022)
6.3.2 North America Complement Drug Market Size by Application (2023-2028)
6.3.3 North America Complement Drug Market Share by Application (2017-2028)
6.4 North America Complement Drug Market Size by Country
6.4.1 North America Complement Drug Market Size by Country (2017-2022)
6.4.2 North America Complement Drug Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Complement Drug Market Size (2017-2028)
7.2 Europe Complement Drug Market Size by Type
7.2.1 Europe Complement Drug Market Size by Type (2017-2022)
7.2.2 Europe Complement Drug Market Size by Type (2023-2028)
7.2.3 Europe Complement Drug Market Share by Type (2017-2028)
7.3 Europe Complement Drug Market Size by Application
7.3.1 Europe Complement Drug Market Size by Application (2017-2022)
7.3.2 Europe Complement Drug Market Size by Application (2023-2028)
7.3.3 Europe Complement Drug Market Share by Application (2017-2028)
7.4 Europe Complement Drug Market Size by Country
7.4.1 Europe Complement Drug Market Size by Country (2017-2022)
7.4.2 Europe Complement Drug Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Complement Drug Market Size (2017-2028)
8.2 Asia-Pacific Complement Drug Market Size by Type
8.2.1 Asia-Pacific Complement Drug Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Complement Drug Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Complement Drug Market Share by Type (2017-2028)
8.3 Asia-Pacific Complement Drug Market Size by Application
8.3.1 Asia-Pacific Complement Drug Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Complement Drug Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Complement Drug Market Share by Application (2017-2028)
8.4 Asia-Pacific Complement Drug Market Size by Region
8.4.1 Asia-Pacific Complement Drug Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Complement Drug Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Complement Drug Market Size (2017-2028)
9.2 Latin America Complement Drug Market Size by Type
9.2.1 Latin America Complement Drug Market Size by Type (2017-2022)
9.2.2 Latin America Complement Drug Market Size by Type (2023-2028)
9.2.3 Latin America Complement Drug Market Share by Type (2017-2028)
9.3 Latin America Complement Drug Market Size by Application
9.3.1 Latin America Complement Drug Market Size by Application (2017-2022)
9.3.2 Latin America Complement Drug Market Size by Application (2023-2028)
9.3.3 Latin America Complement Drug Market Share by Application (2017-2028)
9.4 Latin America Complement Drug Market Size by Country
9.4.1 Latin America Complement Drug Market Size by Country (2017-2022)
9.4.2 Latin America Complement Drug Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Complement Drug Market Size (2017-2028)
10.2 Middle East & Africa Complement Drug Market Size by Type
10.2.1 Middle East & Africa Complement Drug Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Complement Drug Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Complement Drug Market Share by Type (2017-2028)
10.3 Middle East & Africa Complement Drug Market Size by Application
10.3.1 Middle East & Africa Complement Drug Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Complement Drug Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Complement Drug Market Share by Application (2017-2028)
10.4 Middle East & Africa Complement Drug Market Size by Country
10.4.1 Middle East & Africa Complement Drug Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Complement Drug Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Complement Drug Introduction
11.1.4 Novartis AG Revenue in Complement Drug Business (2017-2022)
11.1.5 Novartis AG Recent Developments
11.2 Alexion Pharmaceuticals
11.2.1 Alexion Pharmaceuticals Company Details
11.2.2 Alexion Pharmaceuticals Business Overview
11.2.3 Alexion Pharmaceuticals Complement Drug Introduction
11.2.4 Alexion Pharmaceuticals Revenue in Complement Drug Business (2017-2022)
11.2.5 Alexion Pharmaceuticals Recent Developments
11.3 ChemoCentryx
11.3.1 ChemoCentryx Company Details
11.3.2 ChemoCentryx Business Overview
11.3.3 ChemoCentryx Complement Drug Introduction
11.3.4 ChemoCentryx Revenue in Complement Drug Business (2017-2022)
11.3.5 ChemoCentryx Recent Developments
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Complement Drug Introduction
11.4.4 Roche Revenue in Complement Drug Business (2017-2022)
11.4.5 Roche Recent Developments
11.5 Apellis
11.5.1 Apellis Company Details
11.5.2 Apellis Business Overview
11.5.3 Apellis Complement Drug Introduction
11.5.4 Apellis Revenue in Complement Drug Business (2017-2022)
11.5.5 Apellis Recent Developments
11.6 Regeneron
11.6.1 Regeneron Company Details
11.6.2 Regeneron Business Overview
11.6.3 Regeneron Complement Drug Introduction
11.6.4 Regeneron Revenue in Complement Drug Business (2017-2022)
11.6.5 Regeneron Recent Developments
11.7 Amgen
11.7.1 Amgen Company Details
11.7.2 Amgen Business Overview
11.7.3 Amgen Complement Drug Introduction
11.7.4 Amgen Revenue in Complement Drug Business (2017-2022)
11.7.5 Amgen Recent Developments
11.8 Alnylam
11.8.1 Alnylam Company Details
11.8.2 Alnylam Business Overview
11.8.3 Alnylam Complement Drug Introduction
11.8.4 Alnylam Revenue in Complement Drug Business (2017-2022)
11.8.5 Alnylam Recent Developments
11.9 UCB
11.9.1 UCB Company Details
11.9.2 UCB Business Overview
11.9.3 UCB Complement Drug Introduction
11.9.4 UCB Revenue in Complement Drug Business (2017-2022)
11.9.5 UCB Recent Developments
11.10 InflaRx
11.10.1 InflaRx Company Details
11.10.2 InflaRx Business Overview
11.10.3 InflaRx Complement Drug Introduction
11.10.4 InflaRx Revenue in Complement Drug Business (2017-2022)
11.10.5 InflaRx Recent Developments
11.11 ChemoCentryx
11.11.1 ChemoCentryx Company Details
11.11.2 ChemoCentryx Business Overview
11.11.3 ChemoCentryx Complement Drug Introduction
11.11.4 ChemoCentryx Revenue in Complement Drug Business (2017-2022)
11.11.5 ChemoCentryx Recent Developments
11.12 Innate Pharma
11.12.1 Innate Pharma Company Details
11.12.2 Innate Pharma Business Overview
11.12.3 Innate Pharma Complement Drug Introduction
11.12.4 Innate Pharma Revenue in Complement Drug Business (2017-2022)
11.12.5 Innate Pharma Recent Developments
11.13 Ionis Pharmaceuticals
11.13.1 Ionis Pharmaceuticals Company Details
11.13.2 Ionis Pharmaceuticals Business Overview
11.13.3 Ionis Pharmaceuticals Complement Drug Introduction
11.13.4 Ionis Pharmaceuticals Revenue in Complement Drug Business (2017-2022)
11.13.5 Ionis Pharmaceuticals Recent Developments
11.14 Avant Immunotherapeutics
11.14.1 Avant Immunotherapeutics Company Details
11.14.2 Avant Immunotherapeutics Business Overview
11.14.3 Avant Immunotherapeutics Complement Drug Introduction
11.14.4 Avant Immunotherapeutics Revenue in Complement Drug Business (2017-2022)
11.14.5 Avant Immunotherapeutics Recent Developments
11.15 Pfizer
11.15.1 Pfizer Company Details
11.15.2 Pfizer Business Overview
11.15.3 Pfizer Complement Drug Introduction
11.15.4 Pfizer Revenue in Complement Drug Business (2017-2022)
11.15.5 Pfizer Recent Developments
11.16 Sanofi
11.16.1 Sanofi Company Details
11.16.2 Sanofi Business Overview
11.16.3 Sanofi Complement Drug Introduction
11.16.4 Sanofi Revenue in Complement Drug Business (2017-2022)
11.16.5 Sanofi Recent Developments
11.17 Omeros
11.17.1 Omeros Company Details
11.17.2 Omeros Business Overview
11.17.3 Omeros Complement Drug Introduction
11.17.4 Omeros Revenue in Complement Drug Business (2017-2022)
11.17.5 Omeros Recent Developments
11.18 GenMab
11.18.1 GenMab Company Details
11.18.2 GenMab Business Overview
11.18.3 GenMab Complement Drug Introduction
11.18.4 GenMab Revenue in Complement Drug Business (2017-2022)
11.18.5 GenMab Recent Developments
11.19 Akari Therapeutics
11.19.1 Akari Therapeutics Company Details
11.19.2 Akari Therapeutics Business Overview
11.19.3 Akari Therapeutics Complement Drug Introduction
11.19.4 Akari Therapeutics Revenue in Complement Drug Business (2017-2022)
11.19.5 Akari Therapeutics Recent Developments
11.20 AbbVie
11.20.1 AbbVie Company Details
11.20.2 AbbVie Business Overview
11.20.3 AbbVie Complement Drug Introduction
11.20.4 AbbVie Revenue in Complement Drug Business (2017-2022)
11.20.5 AbbVie Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
Table 1. Global Complement Drug Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Peptides
Table 3. Key Players of Antibodies
Table 4. Key Players of Others
Table 5. Global Complement Drug Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Complement Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Complement Drug Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Complement Drug Market Share by Region (2017-2022)
Table 9. Global Complement Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Complement Drug Market Share by Region (2023-2028)
Table 11. Complement Drug Market Trends
Table 12. Complement Drug Market Drivers
Table 13. Complement Drug Market Challenges
Table 14. Complement Drug Market Restraints
Table 15. Global Complement Drug Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Complement Drug Revenue Share by Players (2017-2022)
Table 17. Global Top Complement Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Complement Drug as of 2021)
Table 18. Ranking of Global Top Complement Drug Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Complement Drug Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Complement Drug Product Solution and Service
Table 22. Date of Enter into Complement Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Complement Drug Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Complement Drug Revenue Market Share by Type (2017-2022)
Table 26. Global Complement Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Complement Drug Revenue Market Share by Type (2023-2028)
Table 28. Global Complement Drug Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Complement Drug Revenue Share by Application (2017-2022)
Table 30. Global Complement Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Complement Drug Revenue Share by Application (2023-2028)
Table 32. North America Complement Drug Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Complement Drug Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Complement Drug Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Complement Drug Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Complement Drug Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Complement Drug Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Complement Drug Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Complement Drug Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Complement Drug Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Complement Drug Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Complement Drug Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Complement Drug Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Complement Drug Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Complement Drug Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Complement Drug Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Complement Drug Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Complement Drug Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Complement Drug Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Complement Drug Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Complement Drug Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Complement Drug Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Complement Drug Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Complement Drug Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Complement Drug Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Complement Drug Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Complement Drug Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Complement Drug Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Complement Drug Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Complement Drug Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Complement Drug Market Size by Country (2023-2028) & (US$ Million)
Table 62. Novartis AG Company Details
Table 63. Novartis AG Business Overview
Table 64. Novartis AG Complement Drug Product
Table 65. Novartis AG Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 66. Novartis AG Recent Developments
Table 67. Alexion Pharmaceuticals Company Details
Table 68. Alexion Pharmaceuticals Business Overview
Table 69. Alexion Pharmaceuticals Complement Drug Product
Table 70. Alexion Pharmaceuticals Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 71. Alexion Pharmaceuticals Recent Developments
Table 72. ChemoCentryx Company Details
Table 73. ChemoCentryx Business Overview
Table 74. ChemoCentryx Complement Drug Product
Table 75. ChemoCentryx Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 76. ChemoCentryx Recent Developments
Table 77. Roche Company Details
Table 78. Roche Business Overview
Table 79. Roche Complement Drug Product
Table 80. Roche Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 81. Roche Recent Developments
Table 82. Apellis Company Details
Table 83. Apellis Business Overview
Table 84. Apellis Complement Drug Product
Table 85. Apellis Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 86. Apellis Recent Developments
Table 87. Regeneron Company Details
Table 88. Regeneron Business Overview
Table 89. Regeneron Complement Drug Product
Table 90. Regeneron Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 91. Regeneron Recent Developments
Table 92. Amgen Company Details
Table 93. Amgen Business Overview
Table 94. Amgen Complement Drug Product
Table 95. Amgen Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 96. Amgen Recent Developments
Table 97. Alnylam Company Details
Table 98. Alnylam Business Overview
Table 99. Alnylam Complement Drug Product
Table 100. Alnylam Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 101. Alnylam Recent Developments
Table 102. UCB Company Details
Table 103. UCB Business Overview
Table 104. UCB Complement Drug Product
Table 105. UCB Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 106. UCB Recent Developments
Table 107. InflaRx Company Details
Table 108. InflaRx Business Overview
Table 109. InflaRx Complement Drug Product
Table 110. InflaRx Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 111. InflaRx Recent Developments
Table 112. ChemoCentryx Company Details
Table 113. ChemoCentryx Business Overview
Table 114. ChemoCentryx Complement Drug Product
Table 115. ChemoCentryx Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 116. ChemoCentryx Recent Developments
Table 117. Innate Pharma Company Details
Table 118. Innate Pharma Business Overview
Table 119. Innate Pharma Complement Drug Product
Table 120. Innate Pharma Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 121. Innate Pharma Recent Developments
Table 122. Ionis Pharmaceuticals Company Details
Table 123. Ionis Pharmaceuticals Business Overview
Table 124. Ionis Pharmaceuticals Complement Drug Product
Table 125. Ionis Pharmaceuticals Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 126. Ionis Pharmaceuticals Recent Developments
Table 127. Avant Immunotherapeutics Company Details
Table 128. Avant Immunotherapeutics Business Overview
Table 129. Avant Immunotherapeutics Complement Drug Product
Table 130. Avant Immunotherapeutics Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 131. Avant Immunotherapeutics Recent Developments
Table 132. Pfizer Company Details
Table 133. Pfizer Business Overview
Table 134. Pfizer Complement Drug Product
Table 135. Pfizer Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 136. Pfizer Recent Developments
Table 137. Sanofi Company Details
Table 138. Sanofi Business Overview
Table 139. Sanofi Complement Drug Product
Table 140. Sanofi Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 141. Sanofi Recent Developments
Table 142. Omeros Company Details
Table 143. Omeros Business Overview
Table 144. Omeros Complement Drug Product
Table 145. Omeros Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 146. Omeros Recent Developments
Table 147. GenMab Company Details
Table 148. GenMab Business Overview
Table 149. GenMab Complement Drug Product
Table 150. GenMab Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 151. GenMab Recent Developments
Table 152. Akari Therapeutics Company Details
Table 153. Akari Therapeutics Business Overview
Table 154. Akari Therapeutics Complement Drug Product
Table 155. Akari Therapeutics Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 156. Akari Therapeutics Recent Developments
Table 157. AbbVie Company Details
Table 158. AbbVie Business Overview
Table 159. AbbVie Complement Drug Product
Table 160. AbbVie Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 161. AbbVie Recent Developments
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Complement Drug Market Share by Type: 2021 VS 2028
Figure 2. Peptides Features
Figure 3. Antibodies Features
Figure 4. Others Features
Figure 5. Global Complement Drug Market Share by Application: 2021 VS 2028
Figure 6. Blood Disease Case Studies
Figure 7. Kidney Disease Case Studies
Figure 8. Others Case Studies
Figure 9. Complement Drug Report Years Considered
Figure 10. Global Complement Drug Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Complement Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Complement Drug Market Share by Region: 2021 VS 2028
Figure 13. Global Complement Drug Market Share by Players in 2021
Figure 14. Global Top Complement Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Complement Drug as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Complement Drug Revenue in 2021
Figure 16. North America Complement Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Complement Drug Market Size Market Share by Type (2017-2028)
Figure 18. North America Complement Drug Market Size Market Share by Application (2017-2028)
Figure 19. North America Complement Drug Market Size Share by Country (2017-2028)
Figure 20. United States Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Complement Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Complement Drug Market Size Market Share by Type (2017-2028)
Figure 24. Europe Complement Drug Market Size Market Share by Application (2017-2028)
Figure 25. Europe Complement Drug Market Size Share by Country (2017-2028)
Figure 26. Germany Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Complement Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Complement Drug Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Complement Drug Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Complement Drug Market Size Share by Region (2017-2028)
Figure 36. China Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Latin America Complement Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Complement Drug Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Complement Drug Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Complement Drug Market Size Share by Country (2017-2028)
Figure 46. Mexico Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Complement Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Complement Drug Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Complement Drug Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Complement Drug Market Size Share by Country (2017-2028)
Figure 52. Turkey Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Novartis AG Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 56. Alexion Pharmaceuticals Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 57. ChemoCentryx Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 58. Roche Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 59. Apellis Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 60. Regeneron Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 61. Amgen Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 62. Alnylam Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 63. UCB Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 64. InflaRx Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 65. ChemoCentryx Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 66. Innate Pharma Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 67. Ionis Pharmaceuticals Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 68. Avant Immunotherapeutics Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 69. Pfizer Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 70. Sanofi Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 71. Omeros Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 72. GenMab Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 73. Akari Therapeutics Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 74. AbbVie Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed